|
Vaccine Detail
pneumococcal polysaccharide conjugate vaccine serotype 1 (PNC-1) |
Vaccine Information |
- Vaccine Name: pneumococcal polysaccharide conjugate vaccine serotype 1 (PNC-1)
- Target Pathogen: Streptococcus pneumoniae
- Target Disease: Pneumonia
- Vaccine Ontology ID: VO_0004265
- Type: Conjugate vaccine
- Status: Research
- Adjuvant:
- Immunization Route: intranasal immunization
|
Host Response |
Mouse Response
- Host Strain: NMRI
- Vaccination Protocol: Mice were immunized i.n. with 0.5 or 2.0 μg of PNC-1 alone or mixed with either LT-K63 or LT-R72 (Jakobsen et al., 1999).
- Immune Response: Administration of PNC-1 i.n. with either LT-K63 or LT-R72 elicited significantly higher antibody responses than the s.c. route for both 0.5- and 2.0-μg doses of PNC-1 in saline (Jakobsen et al., 1999).
- Challenge Protocol: Mice were challenged with 50 μl of pneumococcal suspension i.n. and were allowed to aspirate it into the lungs for 10 min (Jakobsen et al., 1999).
- Efficacy: Immunization i.n. with PNC-1 and LT-K63 or LT-R72 conferred 100% clearance of lung infection caused by serotype 1 pneumococci (Jakobsen et al., 1999).
|
References |
Jakobsen et al., 1999: Jakobsen H, Schulz D, Pizza M, Rappuoli R, Jónsdóttir I. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections. Infection and immunity. 1999; 67(11); 5892-5897. [PubMed: 10531245].
|
|